OBJECTIVES: This study sought to develop a 2-dimensional (2D) intravascular near-infrared fluorescence (NIRF) imaging strategy for investigation of arterial inflammation in coronary-sized vessels. BACKGROUND: Molecular imaging of arterial inflammation could provide new insights into the pathogenesis of acute myocardial infarction stemming from coronary atheromata and implanted stents. Presently, few high-resolution approaches can image inflammation in coronary-sized arteries in vivo. METHODS: A new 2.9-F rotational, automated pullback 2D imaging catheter was engineered and optimized for 360° viewing intravascular NIRF imaging. In conjunction with the cysteine protease-activatable imaging reporter Prosense VM110 (VisEn Medical, Woburn, Massachusetts), intra-arterial 2D NIRF imaging was performed in rabbit aortas with atherosclerosis (n =10) or implanted coronary bare-metal stents (n = 10, 3.5-mm diameter, day 7 post-implantation). Intravascular ultrasound provided coregistered anatomical images of arteries. After sacrifice, specimens underwent ex vivo NIRF imaging, fluorescence microscopy, and histological and immunohistochemical analyses. RESULTS: Imaging of coronary artery-scaled phantoms demonstrated 8-sector angular resolution and submillimeter axial resolution, nanomolar sensitivity to NIR fluorochromes, and modest NIRF light attenuation through blood. High-resolution NIRF images of vessel wall inflammation with signal-to-noise ratios >10 were obtained in real-time through blood, without flushing or occlusion. In atherosclerosis, 2D NIRF, intravascular ultrasound-NIRF fusion, microscopy, and immunoblotting studies provided insight into the spatial distribution of plaque protease activity. In stent-implanted vessels, real-time imaging illuminated an edge-based pattern of stent-induced arterial inflammation. CONCLUSIONS: A new 2D intravascular NIRF imaging strategy provides high-resolution in vivo spatial mapping of arterial inflammation in coronary-sized arteries and reveals increased inflammation-regulated cysteine protease activity in atheromata and stent-induced arterial injury.
OBJECTIVES: This study sought to develop a 2-dimensional (2D) intravascular near-infrared fluorescence (NIRF) imaging strategy for investigation of arterial inflammation in coronary-sized vessels. BACKGROUND: Molecular imaging of arterial inflammation could provide new insights into the pathogenesis of acute myocardial infarction stemming from coronary atheromata and implanted stents. Presently, few high-resolution approaches can image inflammation in coronary-sized arteries in vivo. METHODS: A new 2.9-F rotational, automated pullback 2D imaging catheter was engineered and optimized for 360° viewing intravascular NIRF imaging. In conjunction with the cysteine protease-activatable imaging reporter Prosense VM110 (VisEn Medical, Woburn, Massachusetts), intra-arterial 2D NIRF imaging was performed in rabbit aortas with atherosclerosis (n =10) or implanted coronary bare-metal stents (n = 10, 3.5-mm diameter, day 7 post-implantation). Intravascular ultrasound provided coregistered anatomical images of arteries. After sacrifice, specimens underwent ex vivo NIRF imaging, fluorescence microscopy, and histological and immunohistochemical analyses. RESULTS: Imaging of coronary artery-scaled phantoms demonstrated 8-sector angular resolution and submillimeter axial resolution, nanomolar sensitivity to NIR fluorochromes, and modest NIRF light attenuation through blood. High-resolution NIRF images of vessel wall inflammation with signal-to-noise ratios >10 were obtained in real-time through blood, without flushing or occlusion. In atherosclerosis, 2D NIRF, intravascular ultrasound-NIRF fusion, microscopy, and immunoblotting studies provided insight into the spatial distribution of plaque protease activity. In stent-implanted vessels, real-time imaging illuminated an edge-based pattern of stent-induced arterial inflammation. CONCLUSIONS: A new 2D intravascular NIRF imaging strategy provides high-resolution in vivo spatial mapping of arterial inflammation in coronary-sized arteries and reveals increased inflammation-regulated cysteine protease activity in atheromata and stent-induced arterial injury.
Authors: R Nika Razansky; Amir Rosenthal; George Mallas; Daniel Razansky; Farouc A Jaffer; Vasilis Ntziachristos Journal: Opt Express Date: 2010-05-24 Impact factor: 3.894
Authors: Farouc A Jaffer; Claudio Vinegoni; Michael C John; Elena Aikawa; Herman K Gold; Aloke V Finn; Vasilis Ntziachristos; Peter Libby; Ralph Weissleder Journal: Circulation Date: 2008-10-13 Impact factor: 29.690
Authors: Sergio Waxman; Simon R Dixon; Philippe L'Allier; Jeffrey W Moses; John L Petersen; Donald Cutlip; Jean-Claude Tardif; Richard W Nesto; James E Muller; Michael J Hendricks; Stephen T Sum; Craig M Gardner; James A Goldstein; Gregg W Stone; Mitchell W Krucoff Journal: JACC Cardiovasc Imaging Date: 2009-07
Authors: Gaku Nakazawa; Aloke V Finn; Michael Joner; Elena Ladich; Robert Kutys; Erik K Mont; Herman K Gold; Allen P Burke; Frank D Kolodgie; Renu Virmani Journal: Circulation Date: 2008-08-25 Impact factor: 29.690
Authors: Giovanni J Ughi; Johan Verjans; Ali M Fard; Hao Wang; Eric Osborn; Tetsuya Hara; Adam Mauskapf; Farouc A Jaffer; Guillermo J Tearney Journal: Int J Cardiovasc Imaging Date: 2014-10-24 Impact factor: 2.357
Authors: Amit Saxena; Chase W Kessinger; Brian Thompson; Jason R McCarthy; Yoshiko Iwamoto; Charles P Lin; Farouc A Jaffer Journal: Mol Imaging Biol Date: 2013-06 Impact factor: 3.488